As the year winds down, here's a reflective look at the most-read content published at Bioprocess Online in 2021. The list is heavy with regulatory, vaccine, COVID-19, manufacturing capacity, and supply chain stories in the wake of a year marked by great challenge — and even greater growth opportunity — for biopharma.
We're grateful for the incredible contributing experts who share their insight with our audience. We're also thankful for the support of an industry eager to help biopharma companies overcome their process and manufacturing challenges as they work in earnest to meet patient needs.
Soak up the knowledge, and happy holidays from your friends at Bioprocess Online.
![]()
Matthew Pillar
Bioprocess Online & The Business of Biotech Podcast
|
